Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. FiguresDoxorubicin (Dox) is a frequently used chemotherapeutic agent with heart failure as a major adverse event. While several studies have demonstrated prevention of Dox-induced cardiomyopathy (Dox-CM) in rodents, no translatable therapies have emerged to reverse Dox-CM.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
